Patisiran (sodium) [CAS 1386913-72-9]

Patisiran sodium is a double-stranded small interfering RNA that targets a sequence within the transthyretin (TTR) messenger RNA. Patisiran sodium specifically inhibits hepatic synthesis of mutant and wild-type TTR. Patisiran sodium can be used for the research of hereditary TTR amyloidosis[1][2][3].

[1386913-72-9]

[Patisiran(sodium)]

Small Interfering RNA (siRNA) ; Transthyretin (TTR)

99.09

H2O : 33.33 mg/mL (ultrasonic)

-20°C (Powder, stored under nitrogen, away from moisture)

Blue Ice